Intratumoral delivery of CD154 homolog (Ad-ISF35) induces tumor regression: analysis of vector biodistribution, persistence and gene expression

por Melo-Cardenas, J, Urquiza, M, Kipps, TJ, Castro, JE
Publicado en Cancer Gene Ther (2012)

Chimeric form of tumor necrosis factor-α has enhanced surface expression and antitumor activity

por Rieger, R, Whitacre, D, Cantwell, MJ, Prussak, C, Kipps, TJ
Publicado en Cancer Gene Ther (2008)

Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia

por Castro, JE, Sandoval-Sus, JD, Bole, J, Rassenti, L, Kipps, TJ
Publicado en Leukemia (2008)

A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154

por Wierda, WG, Castro, JE, Aguillon, R, Sampath, D, Jalayer, A, McMannis, J, Prussak, CE, Keating, M, Kipps, TJ
Publicado en Leukemia (2010)

The CLLU1 expression level is a stable and inherent feature of the chronic lymphocytic leukemia clone

por Buhl, AM, Novotny, GW, Josefsson, P, Nielsen, JE, Pedersen, LB, Geisler, C, Rassenti, LZ, Kipps, TJ, Jurlander, J, Leffers, H
Publicado en Leukemia (2009)

Trisomy 12 CLLs progress through NOTCH1 mutations

por Balatti, V, Lerner, S, Rizzotto, L, Rassenti, LZ, Bottoni, A, Palamarchuk, A, Cascione, L, Alder, H, Keating, MJ, Kipps, TJ, Pekarsky, Y, Croce, CM
Publicado 2012

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

por Byrd, J.C., Brown, J.R., O’Brien, S., Barrientos, J.C., Kay, N.E., Reddy, N.M., Coutre, S., Tam, C.S., Mulligan, S.P., Jaeger, U., Devereux, S., Barr, P.M., Furman, R.R., Kipps, T.J., Cymbalista, F., Pocock, C., Thornton, P., Caligaris-Cappio, F., Robak, T., Delgado, J., Schuster, S.J., Montillo, M., Schuh, A., de Vos, S., Gill, D., Bloor, A., Dearden, C., Moreno, C., Jones, J.J., Chu, A.D., Fardis, M., McGreivy, J., Clow, F., James, D.F., Hillmen, P.
Publicado 2014

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia

por Young, E, Noerenberg, D, Mansouri, L, Ljungström, V, Frick, M, Sutton, L-A, Blakemore, SJ, Galan-Sousa, J, Plevova, K, Baliakas, P, Rossi, D, Clifford, R, Roos-Weil, D, Navrkalova, V, Dörken, B, Schmitt, CA, Smedby, KE, Juliusson, G, Giacopelli, B, Blachly, JS, Belessi, C, Panagiotidis, P, Chiorazzi, N, Davi, F, Langerak, AW, Oscier, D, Schuh, A, Gaidano, G, Ghia, P, Xu, W, Fan, L, Bernard, OA, Nguyen-Khac, F, Rassenti, L, Li, J, Kipps, TJ, Stamatopoulos, K, Pospisilova, S, Zenz, T, Oakes, CC, Strefford, JC, Rosenquist, R, Damm, F
Publicado en Leukemia (2016)